Your browser doesn't support javascript.
loading
Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.
Rankin, Andrew; Johnson, Adrienne; Roos, Alison; Kannan, Geoffrey; Knipstein, Jeffrey; Britt, Nicholas; Rosenzweig, Mark; Haberberger, James; Pavlick, Dean; Severson, Eric; Vergilio, Jo-Anne; Squillace, Rachel; Erlich, Rachel; Sathyan, Pratheesh; Cramer, Stuart; Kram, David; Ross, Jeffrey; Miller, Vince; Reddy, Prasanth; Alexander, Brian; Ali, Siraj M; Ramkissoon, Shakti.
Afiliação
  • Rankin A; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Johnson A; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Roos A; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Kannan G; Center for Cancer and Blood Disorders, Pediatric Specialists of Virginia, Falls Church, Virginia, USA.
  • Knipstein J; Pediatric Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Britt N; Foundation Medicine Inc., Morrisville, North, Carolina, USA.
  • Rosenzweig M; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Haberberger J; Foundation Medicine Inc., Morrisville, North, Carolina, USA.
  • Pavlick D; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Severson E; Foundation Medicine Inc., Morrisville, North, Carolina, USA.
  • Vergilio JA; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Squillace R; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Erlich R; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Sathyan P; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Cramer S; University of South Carolina School of Medicine, Columbia, South Carolina, USA.
  • Kram D; Wake Forest Pediatric Oncology, Winston-Salem, North Carolina, USA.
  • Ross J; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Miller V; SUNY Upstate Medical University, Syracuse, New York, USA.
  • Reddy P; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Alexander B; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Ali SM; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
  • Ramkissoon S; Foundation Medicine Inc., Cambridge, Massachusetts, USA.
Oncologist ; 26(1): e153-e163, 2021 01.
Article em En | MEDLINE | ID: mdl-32918774

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Neoplasias Encefálicas / Proteínas Proto-Oncogênicas c-raf / Proteínas Proto-Oncogênicas B-raf / Melanoma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Neoplasias Encefálicas / Proteínas Proto-Oncogênicas c-raf / Proteínas Proto-Oncogênicas B-raf / Melanoma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos